Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...

The new weight-loss drugs were originally developed as a treatment for type ... While a tablet form of semaglutide is already available, this was initially approved as a low-dose version that is less ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

One of the current stars of the biotech world is Viking Therapeutics (NASDAQ: VKTX), and for good reason. The clinical-stage company is advancing to the later stages of developing a drug that, if ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

The Bristol Myers Squibb medicine is said relieve symptoms without causing some of the harsh side effects of drugs already in use. Meanwhile, thousands of patients allege in a lawsuit that drugs used ...

The Food and Drug Administration, as expected, approved KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage is milder side effects.

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...